Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)
Clinical trial NCT02599961 · TERMINATED
Trial details
- NCT number
- NCT02599961
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-10
- Primary completion
- 2019-10-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.